Register

Login

Vet Times logo
+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
    • Crossword
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs
Vet Times logo

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcastsDigital EditionCrossword

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

Vet Times logo 2

About

The team

Advertise with us

Recruitment

Contact us

Vet Times logo 2

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts

Digital Edition

Crossword


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

fb-iconinsta-iconlinkedin-icontwitter-iconyoutube-icon

© Veterinary Business Development Ltd 2025

IPSO_regulated

17 Mar 2021

Dechra extends range with two-pack Osurnia

Otitis externa treatment, part of company’s dermatology portfolio, available as two-tube pack option.

author_img

Vet Times

Job Title



Dechra extends range with two-pack Osurnia

Otitis externa treatment Osurnia is now available as a two-tube pack option.

Dechra Veterinary products said the gel treatment for inflamed, infected canine ears – part of its “extensive dermatology portfolio” – had previously been available in both 20-pack and 40-pack sizes, but the two-tube pack option now offers a complete pre-packaged treatment course for one ear.

Active ingredients

Osurnia contains three active agents:

  • antibiotic florfenicol, which is effective against Staphylococcus pseudintermedius
  • antifungal terbinafine, demonstrated to be effective against Malassezia pachydermatis
  • betamethasone acetate, a glucocorticosteroid that helps relieve discomfort and inflammation

The gel applies like a liquid, so spreads through the ear canal, and the active ingredients remain at high levels in the ear canal for up to 35 days.

‘Convenient solution’

Dechra brand manager Carol Morgan said: “The introduction of a pre-packaged Osurnia treatment course provides a convenient solution to veterinarians treating otitis.

“Osurnia comes in pre-measured, single-dose tubes of the gel with a soft flexible applicator tip that ensures the dog receives the right dose every time, all while minimising discomfort for the patient.

“A treatment plan using Osurnia means that vets can help ensure compliance of treatment. The application of the second dose provides an additional opportunity to assess the patient to ensure it is responding as planned.”

Dechra acquired the worldwide rights to the marketing and manufacture of Osurnia from Elanco Animal Health in 2020, after Elanco divested some of its portfolio as part of its £5 billion acquisition of Bayer Animal Health.

For more, visit Dechra’s website.